WEST BERLIN, N.J.--(BUSINESS WIRE)--EP MedSystems, Inc. (NASDAQ: EPMD), today announced the Company has appointed Gerard J. Michel, to its board of directors and audit committee. Mr. Michel is the Chief Financial Officer and Vice President, Corporate Strategy of NPS Pharmaceuticals, Inc (“NPS”). NPS engages in the discovery, development, and commercialization of small molecules and recombinant proteins. The company’s product candidates are primarily used for the treatment of bone and mineral disorders, gastrointestinal disorders, and central nervous system disorders.
